Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

So, what's the verdict? Don't let short-term hiccups scare you off.

Canopy Growth Stock Is a Buy on the Recent Pullback

Aurora Cannabis

Investors can kiss an expected boost to operating margins goodbye.

More Bad News for the Canadian Marijuana Industry

It’s been a brutal third quarter for cannabis stocks, but Canopy Growth Corp. (NYSE: CGC) is well positioned to exceed growth expectations in the third quarter, one Wall Street analyst says.
 The Analyst: Cantor Fitzgerald analyst Pablo Zuanic reiterated his Neutral rating for Canopy and raised his price target from $20.56 to $20.93.

Cantor Fitzgerald Sees 'Near-Term Upside' For Canopy Growth

American Battery Technology Company

B2Gold

iQIYI

Plug Power

SunPower

Smith & Wesson Brands

While the coronavirus pandemic is thankfully fading in magnitude, the changes it has caused may stay with us for a long time. Here are nine growth stocks that can likely advantage the new normal.

9 Growth Stocks That Could Double During the New Normal

Recreational-use cannabis is the primary source of Canopy Growth's revenue, but international medical-use cannabis is growing fast.

How Canopy Growth Makes Money: Recreational and Medical Marijuana

American Airlines

New Age Beverages

Transocean

High-risk stocks that have under-performed and are likely to remain under-performers with high industry, business and financial risk. 
The post 4 High-Risk Stocks That Aren’t Worth the Trouble appeared first on InvestorPlace.

4 High-Risk Stocks That Aren’t Worth the Trouble

The most likely reason: poor financial results from a top rival.

Why Canopy Growth Stock Is Sliding Today

Aphria

GrowGeneration Corp

Green Thumb Industries Inc.

Despite the pandemic, cannabis sales have continued to expand. Statistics Canada reported that in June, retail sales topped CA$ 201 million.

The Rise Of The Cannabis Industry – But What About Its Players?

SMITHS FALLS, ON and NEW YORK, NY, Sept. 23, 2020 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NYSE: CGC) and Acreage Holdings, Inc. ("Acreage") (CSE:ACRG.A.U, ACRG.B.U) (together, the "Companies") are pleased to announce the implementation of Acreage's...

Canopy Growth and Acreage Implement Amended Arrangement

Tilray Brands

Yes, but expect legalization efforts for recreational use to proceed unevenly from state to state.

Is the U.S. Getting on Board With Marijuana Legalization?

CGC stock continues to struggle, and some investors might be restless. Don't be: Canopy remains the industry leader.

Long-Term Investors Should Stay Bullish On Canopy Growth Stock

A famous lifestyle guru just took the plunge into cannabis-based goods. This is a win for the pro-hemp movement and for CGC stock holders.

The Mainstreaming of Cannabis Is Here and Canopy Growth Is a Strong Buy

Canopy Growth Corporation's (CGC) Chairperson Judy Schmeling Presents at Shareholder/Analyst Call - (Transcript)

This should shake out to around $0.30 per Acreage share.

Canopy Growth to Send Up-Front Payment to Acreage Holdings Shareholders This Week

SMITHS FALLS, ON and NEW YORK, Sept. 18, 2020 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NYSE: CGC) and Acreage Holdings, Inc. ("Acreage") (CSE:ACRG.U, OTCQX: ACRGF, FSE:0VZ) (together, the "Companies") are pleased to announce that Acreage has obtained a final...

Acreage Obtains Final Order for Amended Plan of Arrangement with Canopy Growth and Confirms Record Date for Acreage Shareholders Entitled to Receive the Upfront Payment

Canopy Growth Corporation (CGC) closed the most recent trading day at $16.36, moving -0.24% from the previous trading session.

Canopy Growth Corporation (CGC) Stock Moves -0.24%: What You Should Know

Amplify Alternative Harvest ETF

These marijuana stocks have shown the most resilience and long-term potential in a year where the industry has taken a step back.
The post 3 Marijuana Stocks You Shouldn’t Forget About appeared first on InvestorPlace.

3 Marijuana Stocks You Shouldn’t Forget About

One with strong financial backing, another with consistent profits -- which of these two Canadian pot stocks is a better pick?

Better Cannabis Stock: Canopy Growth vs. Aphria

CGC stock is still heading to zero unless Biden wins the 2020 election. Here's why Canopy and other marijuana stocks need Biden to thrive.

Canopy Growth Is Headed to $0 Without a Biden Victory

Curaleaf Holdings, Inc.

Trulieve Cannabis Corp.

New laws and regulations prompted by COVID-19 are thrusting a new set of industry leaders to the forefront in cannabis investing.

The FANGification of Cannabis Stocks

There could be a lot more smoking going on in New Jersey, Arizona, South Dakota, Montana, and Mississippi after the November vote.

5 States Prepare Vote on Marijuana Legalization in November

At Canopy Growth Group, the main strategy is to initiate acquisitions and then get unreasonably rewarded for it. Year ending March 31,2020, the company spent $320.27 million on share-based compensation.  

Canopy Growth Group continues to burn money faster than it is making it

Amplify Seymour Cannabis ETF

Global X Cannabis ETF

Constellation Brands

AXS Cannabis ETF

Cambria Cannabis ETF

AdvisorShares Pure Cannabis ETF 

Master Class In Cannabis Investing, Part 1 (Podcast Transcript)

Initially, the line consists of four products containing the popular substance.

Canopy Growth Launches Martha Stewart CBD Line

Canopy Growth on Thursday launched a line of hemp-derived CBD gummies, soft-gels and oil drops under the Martha Stewart name.

News for Canopy Growth Stock (CGC)